Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Two‐drug fixed‐dose combinations of blood pressure‐lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost
Abdul Salam, Mark D. Huffman, Raju Kanukula, et al.
Journal of Clinical Hypertension (2020) Vol. 22, Iss. 10, pp. 1769-1779
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial
Mark D. Huffman, Abigail S. Baldridge, Danielle Lazar, et al.
Hypertension Research (2024) Vol. 47, Iss. 6, pp. 1668-1677
Open Access | Times Cited: 9
Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension
Huynh Van Minh, Huy Tran, Long Doan, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 9, pp. 1121-1138
Open Access | Times Cited: 24
The effect of physical activity intervention on blood pressure in 18 low and middle-income countries: a systematic review and meta-analysis of randomized controlled trials
Vahid Monfared, Mohtaram Hashemi, Fatemeh Zeynab Kiani, et al.
Clinical Hypertension (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Characteristics, treatment, and control of hypertension in public primary healthcare centers in Nigeria: baseline results from the Hypertension Treatment in Nigeria Program
Dike Ojji, Abigail S. Baldridge, Ikechukwu A. Orji, et al.
Journal of Hypertension (2022) Vol. 40, Iss. 5, pp. 888-896
Open Access | Times Cited: 20
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension
Anthony Rodgers, Abdul Salam, William C. Cushman, et al.
Global Heart (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Bioequivalence Study of Single-Pill Capsule Formulation of Amlodipine Plus Benazepril in Healthy Chinese Subjects Under Fasting and Fed Conditions
Haojing Song, Bo Qiu, Xue Sun, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1853-1868
Open Access
Acceptability of fixed-dose combination treatments for hypertension in Kenya: A qualitative study using the Theoretical Framework of Acceptability
Daniel Mbuthia, Ruth Willis, Mary Gichagua, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 3, pp. e0003012-e0003012
Open Access
Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial
Abigail S. Baldridge, Mark D. Huffman, Danielle Lazar, et al.
American Heart Journal (2022) Vol. 254, pp. 183-193
Open Access | Times Cited: 14
The HEARTS partner forum—supporting implementation of HEARTS to treat and control hypertension
Taskeen Khan, Andrew E. Moran, Pablo Perel, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
Fixed‐dose combination therapy‐based protocol compared with free pill combination protocol: Results of a cluster randomized trial
Olutobi Adekunle Sanuade, Boni Maxime Ale, Abigail S. Baldridge, et al.
Journal of Clinical Hypertension (2023) Vol. 25, Iss. 2, pp. 127-136
Open Access | Times Cited: 6
Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India
Gautam Satheesh, Abhishek Sharma, Sandra Puthean, et al.
Tropical Medicine & International Health (2020) Vol. 25, Iss. 12, pp. 1467-1479
Open Access | Times Cited: 14
Polypills for the prevention of cardiovascular disease: a framework for wider use
Anushka Patel, Dike Ojji, H Asita de Silva, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 226-229
Closed Access | Times Cited: 8
Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal
Abhishek Sharma, Warren Kaplan, Gautam Satheesh, et al.
Global Heart (2021) Vol. 16, Iss. 1, pp. 38-38
Open Access | Times Cited: 10
Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk
Vivencio Barrios, Carlos Escobar
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 7, pp. 793-806
Closed Access | Times Cited: 10
Eficacia de una estrategia estandarizada y simplificada para tratamiento de la hipertensión arterial en Chile: la Iniciativa HEARTS en las Américas
Luis Michea, Luis Toro, Natali Alban, et al.
Revista Panamericana de Salud Pública (2022) Vol. 46, pp. 1-1
Open Access | Times Cited: 7
A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
Gautam Satheesh, Bishal Gyawali, Marie Chan Sun, et al.
Global Heart (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
A Cross-Sectional Survey of Fixed-Dose Combination Antihypertensive Medicine Prescribing in Twenty-Four Countries, Including Qualitative Insights
Edel O’Hagan, Daniel McIntyre, Tu Ngoc Nguyen, et al.
Global Heart (2024) Vol. 19, Iss. 1, pp. 73-73
Open Access | Times Cited: 1
Prices of combination medicines and single‐molecule antihypertensive medicines in India's private health care sector
Sagri Negi, Dinesh Neupane, Swagata Kumar Sahoo, et al.
Journal of Clinical Hypertension (2020) Vol. 23, Iss. 4, pp. 738-743
Open Access | Times Cited: 10
The Safety and Efficacy of Quadruple Ultra-Low-Dose Combination (Quadpill) for Hypertension Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Mohamed Abuelazm, Shafaqat Ali, Othman Saleh, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 11, pp. 813-826
Open Access | Times Cited: 3
Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations
Qin Li, Nancy Zhang, Junichi Ishigami, et al.
Journal of Human Hypertension (2021) Vol. 36, Iss. 11, pp. 989-995
Closed Access | Times Cited: 5
Acceptability of fixed-dose combination treatments for hypertension in Kenya: a qualitative study using the Theoretical Framework of Acceptability
Daniel Mbuthia, Ruth Willis, Mary Gichagua, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Adherence to the treatment in patients with hypertension during the war in Ukraine
Vira Tseluyko, L. M. Yakovleva
EMERGENCY MEDICINE (2024) Vol. 20, Iss. 4, pp. 251-258
Open Access
Evaluation of levamlodipine benzenesulfonate compound I for embryo-fetal developmental toxicity in SD rats and genotoxicity
Yijun Tian, Wenjing Shi, Fengjiang Liu, et al.
Reproductive Toxicology (2024) Vol. 129, pp. 108676-108676
Closed Access
Relationship between Prices of Fixed-dose and Free-equivalent Combination: A Survey of Medicines in China's National Reimbursement Drug List
YIMAN FENG, Wei Li, Jiayun Wang, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top